EV/EBITDA
-13.13
+0.82+5.88%
2 min ago
Summary
- As of February 25, 2025, AKRO EV/EBITDA is -13.13, with a rise of +0.82 (+5.88%) during the most recent trading day.
- Over the past year, AKRO EV/EBITDA has dropped by -5.00 (-61.50%).
- AKRO EV/EBITDA is now -1022.22% below its all-time high of -1.17.
Performance
AKRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.9% | -5.9% | -5.5% |
| 1 m1 month | -73.5% | +73.5% | +63.4% |
| 3 m3 months | -57.8% | +57.7% | +50.5% |
| 6 m6 months | -62.1% | +88.5% | +75.1% |
| ytdytd | -88.4% | +88.4% | +75.4% |
| 1 y1 year | -61.5% | +152.8% | +89.9% |
| 5 y5 years | -4.5% | +433.0% | +114.0% |
AKRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -73.5% | -15.84 | +17.1% | |
| 3 m | 3-month | -5.35 | -145.4% | -15.84 | +17.1% |
| 6 m | 6-month | -5.35 | -145.4% | -15.84 | +17.1% |
| 1 y | 1-year | -3.86 | -240.2% | -15.84 | +17.1% |
| 3 y | 3-year | -1.17 | -1022.2% | -26.86 | +51.1% |
| 5 y | 5-year | -1.17 | -1022.2% | -26.86 | +51.1% |
| alltime | all time | -1.17 | -1022.2% | -38.76 | +66.1% |
Akero Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -13.13(+88.4%) |
| 2024 | -6.97(-5.7%) |
| 2023 | -7.39(-64.7%) |
| Date | Value |
|---|---|
| 2022 | -20.92(+257.6%) |
| 2021 | -5.85(-34.0%) |
| 2020 | -8.87(-28.9%) |
| 2019 | -12.47 |
FAQ
- What is Akero Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akero Therapeutics?
- What is AKRO EV/EBITDA year-to-date change?
- What is Akero Therapeutics EV/EBITDA year-on-year change?
What is Akero Therapeutics EV/EBITDA?
The current EV/EBITDA of AKRO is -13.13
What is the all time high EV/EBITDA for Akero Therapeutics?
Akero Therapeutics all-time high EV/EBITDA is -1.17
What is AKRO EV/EBITDA year-to-date change?
Akero Therapeutics EV/EBITDA has changed by -6.16 (-88.38%) since the beginning of the year
What is Akero Therapeutics EV/EBITDA year-on-year change?
Over the past year, AKRO EV/EBITDA has changed by -5.00 (-61.50%)